5 Most Promising Companies offering hope to patients with Niemann-Pick Type C
Por um escritor misterioso
Descrição
Niemann–Pick is a rare autosomal recessive inherited disease that is characterized by excessive accumulation of cholesterol and lipids in cells, leading to apoptosis and neural degeneration. The disease affects numerous body parts such as the brain, nerves, liver, spleen, bone marrow and lungs. Those suffering from the disease suffer from lack of coordination, dystonia; sleep disturbances, difficult in eating and swallowing and frequent bouts of pneumonia.
5 Most Promising Companies offering hope to patients with Niemann-Pick Type C
5 Most Promising Companies offering hope to patients with Niemann-Pick Type C
5 Most Promising Companies offering hope to patients with Niemann-Pick Type C
Investigation of 2-Hydroxypropyl-β-Cyclodextrin Treatment in a Neuronal-Like Cell Model of Niemann–Pick Type C Using Quantitative Proteomics
First Life Saved with AI-Discovered Repurposed Medicine for Castleman Disease with Significant Potential Applications to Treat Other Illnesses
Precision medicine in monogenic inflammatory bowel disease: proposed mIBD REPORT standards
Endpoint Considerations to FacilitateDrug Development for Niemann-Pick Type C (NPC)
2022 drug approvals: Biopharma delivered 34 new drugs
5 Most Promising Companies offering hope to patients with Niemann-Pick Type C
We the Scientists: How a Daring Team of Parents and Doctors Forged a New Path for Medicine: Dockser Marcus, Amy: 9780399576133: : Books
Cyclo Therapeutics, Inc. – NNPDF
Advancements in Niemann-Pick Disease Type C Treatments
Orphazyme sells entire business to US biotech company — MedWatch
de
por adulto (o preço varia de acordo com o tamanho do grupo)